Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections

SHANGHAI and HONG KONG, July 26, 2021 /PRNewswire/ -- In June 2021, results from a preclinical study jointly conducted by Antengene, American biopharmaceutical company Karyopharm Therapeutics andUniversity of Georgia College of Veterinary Medicine has been published in a paper titled "selinexor, ...

2021-07-26 08:44 2084

Antengene and Its Partners Publish Preclinical Data Demonstrating the Encouraging Activity of Selinexor in the Prevention and Treatment of SARS-CoV-2 Infections

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors

SAN FRANCISCO and SUZHOU, China, July 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-26 08:00 5901

ZumVet launches first virtual veterinary platform in Hong Kong

HONG KONG, July 26, 2021 /PRNewswire/ -- Singapore-based pet telehealth startup ZumVet today announced the launch of its platform inHong Kong, a remote care solution offering a full suite of home-based health and wellness services for pets. This is the first pet-centric app of its kind inHong ...

2021-07-26 06:00 2833

ZumVet launches first virtual veterinary platform in Hong Kong

The Global Self-Care Federation Highlights the Need to Take Action on Self-Care to Create Better Health Outcomes for All

GENÈVE, Switzerland, July 23, 2021 /PRNewswire/ -- On the occasion of International Self-Care Day 2021 and WHO Self-Care month, The Global Self-Care Federation (GSCF) underscores the importance of acting on self-care by engaging in positive and consistent self-care practices. Self-care produces o...

2021-07-23 21:41 2929

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to contin...

2021-07-23 21:02 8473

Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand

AMSTERDAM, Netherlands and LOUISVILLE, Ky., July 23, 2021 /PRNewswire/ -- NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), aKentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will r...

2021-07-23 16:00 1555

Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac

Presentation of 36 abstracts underscore the potential of Elekta Unity to advance precision radiation medicine ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Uni...

2021-07-23 14:17 7620

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world's first artificial intelligence technology for complex cardiac arrhythmia procedures

AUSTIN, Texas, July 23, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures.Andrea...

2021-07-23 03:26 2318

FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH

VANCOUVER, British Columbia, July 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB: BVAXF)("BioVaxys"), is pleased to announce today that the US Food and Drug Administration ("FDA") has provided its official Written Response to the Company's request for a Pre-IN...

2021-07-22 21:50 8881

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu

RARITAN, N.J., July 22, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho's VITROS® Critical Care menu, is now ...

2021-07-22 21:00 7590

Mentice publishes the company's interim report for the period January-June 2021

- Mentice delivers record level of sales for the second quarter and first half year STOCKHOLM, July 22, 2021 /PRNewswire/ -- Second quarter (April–June 2021) and first half year (January-June 2021) * Order intake amounted to 40.2 (28.4) MSEK for the second quarter and 80.1 (60.9) MSEK for th...

2021-07-22 15:25 1524

Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab)

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement AHMEDABAD, India, July 22, 2021 /PRNewswire/ -- Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high...

2021-07-22 13:00 2571

Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly

* Acquisition of Cialis® in the People's Republic of China to bolster Menarini's Men's Health portfolio and drive multichannel coverage * This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in...

2021-07-22 10:00 2805

Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma

SHANGHAI and HONG KONG, July 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-07-22 09:27 2316

Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants

TIANJIN, China, July 22, 2021 /PRNewswire/ -- Joysbio, one of the world's leading manufacturers of lateral flow rapid test kits, has proven that their SARS-CoV-2 (COVID-19) antigen tests can detect new variants, including the Delta variant that's sweeping the world. With over 100 million tests so...

2021-07-22 08:37 2576

China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma

HANGZHOU, China and SHAOXING, China, July 22, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of ASC40 combined with Bevacizumab for treatment of patients w...

2021-07-22 08:30 2270

Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals

New solutions deliver value to hospitals by improving patient care through increased adherence to patient repositioning protocols, according to providers surveyed by Frost & Sullivan SANTA CLARA, Calif., July 22, 2021 /PRNewswire/ -- Even as the incidence of many other healthcare complications i...

2021-07-22 00:30 1538

AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA

GUANGZHOU, China, July 21, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, onJuly 13, 2021, was awarded aBreakthrough Device Designation ("BTD")[1] by the US Food and Drug Administration (FDA) for UriFind (or "the Test"), an early detect...

2021-07-21 21:02 2016

ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

GOLDEN, Colo., July 21, 2021 /PRNewswire/ -- ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device "ArcScan Insight® 100, " headquartered inGolden, Colorado, announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. ("Hao...

2021-07-21 20:33 7998

Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company

SUZHOU, China and ROCKVILLE, Md., July 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Administration (F...

2021-07-21 18:37 3716

1 ... 225 226 227228229 230 231 ... 383